Mostrar el registro sencillo del ítem
In Vitro Activity of Tedizolid against Mycobacterium tuberculosis
| dc.contributor.author | Ruiz Martínez, P. | |
| dc.contributor.author | Causse, Manuel | |
| dc.contributor.author | Vaquero Abellán, Manuel | |
| dc.contributor.author | Casal Román, Manuel | |
| dc.date.accessioned | 2024-01-10T15:36:04Z | |
| dc.date.available | 2024-01-10T15:36:04Z | |
| dc.date.issued | 2019 | |
| dc.identifier.uri | http://hdl.handle.net/10396/26486 | |
| dc.description.abstract | Tedizolid is a novel oxazolidinone with activities against Gram-positive microorganisms, including mycobacteria. We studied the in vitro activity of tedizolid against 120 Mycobacterium tuberculosis strains, including susceptible, first-line-resistant, and multidrug-resistant isolates. MIC was tested using the Bactec 960 MGIT system. MIC90 and MIC50 were 0.5 and 0.25 g/ml, respectively, in susceptible and resistant strains. Tedizolid may be an alternative in the treatment of resistant M. tuberculosis. | es_ES |
| dc.format.mimetype | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | American Society for Microbiology | es_ES |
| dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/ | es_ES |
| dc.source | Ruiz, P., Causse, M., Vaquero, M., & Casal, M. (2019). In vitro activity of tedizolid against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 63(4). https://doi.org/10.1128/aac.01939-18 | es_ES |
| dc.subject | Mycobacterium tuberculosis | es_ES |
| dc.subject | Resistance | es_ES |
| dc.subject | Tedizolid | es_ES |
| dc.title | In Vitro Activity of Tedizolid against Mycobacterium tuberculosis | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publisherversion | http://dx.doi.org/10.1128/AAC.01939-18 | es_ES |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | es_ES |
